Rare Presentations of Primary Melanoma and Special Populations
Lisa A. Kottschade(Mayo Clinic in Arizona), Svetomir N. Markovic(Mayo Clinic in Arizona), David C. Swanson(Mayo Clinic in Arizona), Lori A. Erickson, Steven L. Moran(WinnMed), Nabil Wasif(WinnMed), Roxana Dronca(Dana-Farber Cancer Institute), Jesse T. Nguyen, Judith S. Kaur(Mayo Clinic in Florida), Travis E. Grotz(Mayo Clinic in Arizona), Riten Kumar(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Diva R. Salomão(Mayo Clinic in Arizona), Shane Y. Morita(University of Hawaiʻi at Mānoa), James W. Jakub(Mayo Clinic in Arizona), José S. Pulido(Wills Eye Hospital), Sanjay P. Bagaria(WinnMed), Jennifer L. Hand, Robert C. Miller(Mayo Clinic), Emily C. Nguyen, Val J. Lowe(Mayo Clinic), Jerry D. Brewer(Mayo Clinic), Christian L. Baum(University of Iowa Hospitals and Clinics)
Cited by 35
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
|New England Journal of Medicine|2013|3.4k
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
|The Lancet|2014|1.8k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k